Clinical Trial Update: Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of enzastaurin in pediatric patients with refractory brain and central nervous system tumors and neuroblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Neuroblastoma

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors, Neuroblastoma | Phase 1 | Status: COMPLETED